Alpha 2.0
Login Register
» Authors » Darrell L Lange

Darrell L Lange

Explore the profile of Darrell L Lange including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 51
Followers 0
Related Specialties
Dermatology
Orthopedics
Emergency Medicine
Top 10 Co-Authors
Jaime E Dickerson Jr
Herbert B Slade
Travis A Motley
Adrienne M Gilligan
Joseph M Caporusso
Curtis R Waycaster
Robert A Eichelkraut
Lei Shi
Shawn M Cazzell
D Innes Cargill
Published In
J Foot Ankle Res
Adv Wound Care (New Rochelle)
Wounds
J Am Podiatr Med Assoc
Affiliations
Soon will be listed here.
Recent Articles
1.
Clinical Outcomes for Diabetic Foot Ulcers Treated with Clostridial Collagenase Ointment or with a Product Containing Silver
Motley T, Caporusso J, Lange D, Eichelkraut R, Cargill D, Dickerson Jr J
Adv Wound Care (New Rochelle) . 2018 Oct; 7(10):339-348. PMID: 30374419
To compare outcomes of diabetic foot ulcers (DFUs) treated with clostridial collagenase ointment (CCO) or silver-containing products, both in combination with sharp debridement as needed. One hundred two subjects with...
2.
Enzymatic Debridement of Chronic Nonischemic Diabetic Foot Ulcers: Results of a Randomized, Controlled Trial
Jimenez J, Agnew P, Mayer P, Clements J, Caporusso J, Lange D, et al.
Wounds . 2017 Mar; 29(5):133-139. PMID: 28267678
No abstract available.
3.
Erratum to: Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial
Motley T, Gilligan A, Lange D, Waycaster C, Dickerson Jr J
J Foot Ankle Res . 2016 Aug; 9:28. PMID: 27493688
[This corrects the article DOI: 10.1186/s13047-015-0065-x.].
4.
The Management of Diabetic Foot Ulcers with Porcine Small Intestine Submucosa Tri-Layer Matrix: A Randomized Controlled Trial
Cazzell S, Lange D, Dickerson Jr J, Slade H
Adv Wound Care (New Rochelle) . 2015 Dec; 4(12):711-718. PMID: 26634183
This study demonstrates that superior outcomes are possible when diabetic foot ulcers (DFU) are managed with tri-layer porcine small intestine submucosa (SIS). Patients with DFU from 11 centers participated in...
5.
Anti-inflammatory Effects of Clostridial Collagenase Results from In Vitro and Clinical Studies
Galperin R, Lange D, Ramsay S, Shi L, Weedon K, Hudson N, et al.
J Am Podiatr Med Assoc . 2015 Oct; 105(6):509-19. PMID: 26437320
Background: Digestion of collagen with clostridial collagenase (CC) produces peptides that can induce cellular responses consistent with wound healing in vivo. However, nonhealing human wounds are typically in a state...
6.
Clinical outcomes associated with serial sharp debridement of diabetic foot ulcers with and without clostridial collagenase ointment
Motley T, Lange D, Dickerson Jr J, Slade H
Wounds . 2015 Apr; 26(3):57-64. PMID: 25860329
Objective: Fifty-five subjects with diabetes mellitus type 1 or 2 and a neuropathic, nonischemic foot ulcer were enrolled into this randomized, controlled, multicenter trial designed to examine the effects of...
7.
Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial
Motley T, Gilligan A, Lange D, Waycaster C, Dickerson Jr J
J Foot Ankle Res . 2015 Mar; 8:7. PMID: 25767565
Background: Approximately 10%-15% of people with diabetes develop at least one foot ulcer during their lifetime. Treatment of diabetic foot ulcers (DFUs) represents a significant economic burden. Enzymatic debridement with...